CRISPR-Based Diagnostics Market : Size, Trends, and Growth Analysis 2032
The CRISPR-Based Diagnostics Market is emerging as a transformative segment within the global diagnostics industry, driven by the revolutionary capabilities of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology. Valued at US$ 3,102.33 million in 2024, the market is projected to grow at a robust CAGR of 16.93% from 2025 to 2032. This growth trajectory is fueled by increasing demand for accurate, rapid, and cost-effective diagnostic tools, along with the expanding applications of CRISPR beyond gene editing into point-of-care testing and infectious disease detection.
https://analystviewmarketinsights.com/reports/report-highlight-crispr-based-diagnostics-market